Literature DB >> 22058702

Di-μ-chlorido-bis-[diacetonitrile-chlorido-oxidovanadium(IV)].

Dalibor Dastych, Pavel Rotter, Gabriel Demo, Lenka Dastychová.   

Abstract

The title compound, [V(2)Cl(4)O(2)(CH(3)CN)(4)], is a centrosymmetric dinuclear V(IV) complex associated with four mol-ecules of acetonitrile. The coordination around both V(IV) atoms is essentially square-planar, involving three Cl atoms and one O atom [maximum deviation = 0.017 (3) Å for the O atom]. The augmented octahedral coordination of the metal atom is completed by the N atoms of acetonitrile ligands. The V(IV) atoms are linked by two Cl atoms, acting as bridging atoms. The crystal studied was a non-merohedral twin with a ratio of the two twin components of 0.8200 (3):0.1800 (3). Although Cl and O atoms are present as potential acceptors in the title compound, no hydrogen bonds were observed in the crystal structure.

Entities:  

Year:  2011        PMID: 22058702      PMCID: PMC3201240          DOI: 10.1107/S1600536811037184

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of vanadium(IV) compounds, see: D’Cruz et al. (2003 ▶); Lopez et al. (1976 ▶); Lu et al. (2001 ▶); Shi et al. (1996 ▶). For Ziegler–Natta catalysts, see: Hagen et al. (2002 ▶). For the synthesis of chloridooxidovanadium(IV) complexes, see: du Preez & Sadle (1967 ▶); Homden et al. (2009 ▶); Kern (1962 ▶); Papoutsakis et al. (2004 ▶); Priebsch & Rehder (1990 ▶).

Experimental

Crystal data

[V2Cl4O2(C2H3N)4] M = 439.90 Triclinic, a = 7.0242 (6) Å b = 8.1388 (6) Å c = 8.7118 (5) Å α = 86.536 (6)° β = 66.806 (7)° γ = 74.374 (7)° V = 440.28 (6) Å3 Z = 1 Mo Kα radiation μ = 1.67 mm−1 T = 120 K 0.30 × 0.20 × 0.15 mm

Data collection

Oxford Diffraction Xcalibur Sapphire2 diffractometer Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2009 ▶) T min = 0.804, T max = 1.000 1550 measured reflections 1550 independent reflections 1432 reflections with I > 2σ(I)

Refinement

R[F 2 > 2σ(F 2)] = 0.031 wR(F 2) = 0.103 S = 1.25 1550 reflections 94 parameters H-atom parameters constrained Δρmax = 0.47 e Å−3 Δρmin = −0.51 e Å−3 Data collection: CrysAlis CCD (Oxford Diffraction, 2009 ▶); cell refinement: CrysAlis RED (Oxford Diffraction, 2009 ▶); data reduction: CrysAlis RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶) and PLATON (Spek, 2009 ▶); molecular graphics: Mercury (Macrae et al., 2008 ▶); software used to prepare material for publication: SHELXL97. Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536811037184/ru2013sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811037184/ru2013Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
[V2Cl4O2(C2H3N)4]Z = 1
Mr = 439.90F(000) = 218
Triclinic, P1Dx = 1.659 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.7107 Å
a = 7.0242 (6) ÅCell parameters from 5307 reflections
b = 8.1388 (6) Åθ = 3.3–25.0°
c = 8.7118 (5) ŵ = 1.67 mm1
α = 86.536 (6)°T = 120 K
β = 66.806 (7)°Block, blue
γ = 74.374 (7)°0.30 × 0.20 × 0.15 mm
V = 440.28 (6) Å3
Oxford Diffraction Xcalibur Sapphire2 diffractometer1550 independent reflections
Radiation source: Enhance (Mo) X-ray Source1432 reflections with I > 2σ(I)
graphiteRint = 0.000
Detector resolution: 8.4 pixels mm-1θmax = 25.0°, θmin = 3.3°
ω scansh = −7→8
Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2009)k = −9→9
Tmin = 0.804, Tmax = 1.000l = −9→10
1550 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.031Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.103H-atom parameters constrained
S = 1.25w = 1/[σ2(Fo2) + (0.0397P)2 + 1.0484P] where P = (Fo2 + 2Fc2)/3
1550 reflections(Δ/σ)max < 0.001
94 parametersΔρmax = 0.47 e Å3
0 restraintsΔρmin = −0.51 e Å3
Experimental. empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
V10.58161 (10)0.06353 (8)0.67541 (8)0.0141 (2)
Cl10.71230 (14)−0.15703 (11)0.46017 (11)0.0172 (2)
Cl20.38000 (14)0.30593 (12)0.85537 (12)0.0201 (2)
O10.7642 (4)−0.0069 (3)0.7454 (3)0.0192 (6)
N20.7440 (5)0.2175 (4)0.5012 (4)0.0197 (7)
C40.9873 (6)0.3945 (5)0.3008 (5)0.0228 (8)
H4A0.89810.50710.29160.034*
H4B1.06450.33510.19010.034*
H4C1.09110.40830.34480.034*
C20.1588 (7)−0.2589 (5)1.0454 (5)0.0241 (9)
H2A0.0118−0.22741.05000.036*
H2B0.1555−0.23851.15630.036*
H2C0.2258−0.38011.01050.036*
N10.3766 (5)−0.0747 (4)0.8326 (4)0.0190 (7)
C30.8514 (6)0.2950 (5)0.4132 (5)0.0193 (8)
C10.2821 (6)−0.1565 (5)0.9263 (5)0.0190 (8)
U11U22U33U12U13U23
V10.0142 (3)0.0150 (3)0.0125 (3)−0.0029 (2)−0.0051 (3)−0.0007 (2)
Cl10.0173 (4)0.0172 (5)0.0155 (5)−0.0002 (3)−0.0071 (4)−0.0039 (3)
Cl20.0191 (5)0.0192 (5)0.0197 (5)−0.0014 (4)−0.0066 (4)−0.0054 (4)
O10.0197 (14)0.0202 (14)0.0188 (14)−0.0028 (11)−0.0100 (11)−0.0016 (11)
N20.0180 (16)0.0195 (17)0.0177 (17)−0.0033 (14)−0.0039 (14)−0.0002 (14)
C40.025 (2)0.024 (2)0.020 (2)−0.0099 (17)−0.0079 (17)0.0039 (16)
C20.025 (2)0.024 (2)0.023 (2)−0.0136 (17)−0.0040 (17)0.0005 (17)
N10.0219 (16)0.0209 (17)0.0135 (16)−0.0070 (14)−0.0051 (14)−0.0010 (14)
C30.0182 (19)0.019 (2)0.020 (2)0.0008 (16)−0.0096 (17)−0.0040 (16)
C10.0200 (19)0.0182 (19)0.019 (2)−0.0030 (16)−0.0087 (16)−0.0028 (16)
V1—O11.588 (3)C4—H4A0.9800
V1—N12.085 (3)C4—H4B0.9800
V1—N22.086 (3)C4—H4C0.9800
V1—Cl22.3399 (10)C2—C11.448 (6)
V1—Cl12.3969 (10)C2—H2A0.9800
V1—Cl1i2.6836 (10)C2—H2B0.9800
Cl1—V1i2.6836 (10)C2—H2C0.9800
N2—C31.139 (5)N1—C11.138 (5)
C4—C31.453 (6)
O1—V1—N194.79 (14)C3—N2—V1171.8 (3)
O1—V1—N295.52 (14)C3—C4—H4A109.5
N1—V1—N2169.69 (13)C3—C4—H4B109.5
O1—V1—Cl299.62 (10)H4A—C4—H4B109.5
N1—V1—Cl289.60 (9)C3—C4—H4C109.5
N2—V1—Cl288.90 (9)H4A—C4—H4C109.5
O1—V1—Cl196.44 (10)H4B—C4—H4C109.5
N1—V1—Cl189.01 (9)C1—C2—H2A109.5
N2—V1—Cl189.61 (9)C1—C2—H2B109.5
Cl2—V1—Cl1163.95 (4)H2A—C2—H2B109.5
O1—V1—Cl1i174.92 (10)C1—C2—H2C109.5
N1—V1—Cl1i84.57 (9)H2A—C2—H2C109.5
N2—V1—Cl1i85.15 (9)H2B—C2—H2C109.5
Cl2—V1—Cl1i85.42 (3)C1—N1—V1172.0 (3)
Cl1—V1—Cl1i78.53 (4)N2—C3—C4179.6 (4)
V1—Cl1—V1i101.47 (4)N1—C1—C2179.1 (4)
O1—V1—Cl1—V1i179.36 (11)Cl2—V1—Cl1—V1i−0.47 (16)
N1—V1—Cl1—V1i84.66 (9)Cl1i—V1—Cl1—V1i0.0
N2—V1—Cl1—V1i−85.13 (9)
  9 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Vanadium ion inhibition of alkaline phosphatase-catalyzed phosphate ester hydrolysis.

Authors:  V Lopez; T Stevens; R N Lindquist
Journal:  Arch Biochem Biophys       Date:  1976-07       Impact factor: 4.013

3.  Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4).

Authors:  B Lu; D Ennis; R Lai; E Bogdanovic; R Nikolov; L Salamon; C Fantus; H Le-Tien; I G Fantus
Journal:  J Biol Chem       Date:  2001-07-19       Impact factor: 5.157

4.  Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Authors:  Osmond J D'Cruz; Yanhong Dong; Fatih M Uckun
Journal:  Biochem Biophys Res Commun       Date:  2003-03-07       Impact factor: 3.575

5.  Structural and magnetic properties of vanadyl dichloride solvates: from molecular units to extended hydrogen-bonded solids.

Authors:  Dimitris Papoutsakis; Andrew S Ichimura; Victor G Young; James E Jackson; Daniel G Nocera
Journal:  Dalton Trans       Date:  2003-12-05       Impact factor: 4.390

6.  Vanadium(IV) causes 2'-deoxyguanosine hydroxylation and deoxyribonucleic acid damage via free radical reactions.

Authors:  X Shi; P Wang; H Jiang; Y Mao; N Ahmed; N Dalal
Journal:  Ann Clin Lab Sci       Date:  1996 Jan-Feb       Impact factor: 1.256

7.  Homogeneous vanadium-based catalysts for the Ziegler-Natta polymerization of alpha-olefins.

Authors:  Henk Hagen; Jaap Boersma; Gerard van Koten
Journal:  Chem Soc Rev       Date:  2002-11       Impact factor: 54.564

8.  Synthesis, structure and ethylene polymerisation behaviour of vanadium(IV and V) complexes bearing chelating aryloxides.

Authors:  Damien Homden; Carl Redshaw; Lee Warford; David L Hughes; Joseph A Wright; Sophie H Dale; Mark R J Elsegood
Journal:  Dalton Trans       Date:  2009-07-07       Impact factor: 4.390

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.